# Scopus BioPharma Inc.: Form D filings

Scopus BioPharma Inc., a pharmaceuticals company in New York, NY, filed 6 Form D notices with the SEC between 2019 and 2021. The latest, on December 7, 2021, reports $9.8 million sold of a $9.8 million offering to 4 investors.

Find out what Scopus BioPharma Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Scopus%20BioPharma%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Scopus%20BioPharma%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fscopus-biopharma-inc-1772028)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Scopus%20BioPharma%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Scopus%20BioPharma%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fscopus-biopharma-inc-1772028)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 420 LEXINGTON AVE., SUITE 300, New York, NY, 10170
- Phone: (212) 479-2513
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2017
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1772028

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 7, 2021 | New notice | $9,750,000 | $9,750,000 | $0 | 4 | Nov 23, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1772028/000110465921147286/0001104659-21-147286-index.htm) |
| Jul 10, 2020 | New notice | $6,346,322 | $6,346,322 | $0 | 20 | Jun 10, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1772028/000177202820000004/0001772028-20-000004-index.htm) |
| Jul 10, 2020 | New notice | $636,230 | $636,230 | $0 | 6 | Feb 24, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1772028/000177202820000003/0001772028-20-000003-index.htm) |
| Jul 10, 2020 | Amendment | $2,252,000 | $1,911,600 | $340,400 | 24 | Dec 23, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1772028/000177202820000002/0001772028-20-000002-index.htm) |
| Jul 10, 2020 | New notice | $500,000 | $252,000 | $248,000 | 3 | Dec 23, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1772028/000177202820000001/0001772028-20-000001-index.htm) |
| Aug 8, 2019 | New notice | $600,000 | $450,507 | $149,493 | 17 | Jul 25, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1772028/000177202819000002/0001772028-19-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Paul E. Hopper | Director |  |
| Raphael A. Hofstein | Director |  |
| Ashish P. Sanghrajka | Director |  |
| David S. Battleman | Director |  |
| Ira Scott Greenspan | Executive Officer, Director |  |
| David A. Buckel | Director |  |
| Joshua Lamstein | Executive Officer, Director |  |
| Robert J. Gibson | Executive Officer, Director |  |
| David P. Weild | Director |  |

## Other pharmaceuticals companies in New York that filed recently

- [NBO Pharma Inc.](https://specstream.ai/data/form-d/company/nbo-pharma-inc-2103906) $238,000 · Nov 9, 2026
- [Pierrepont Therapeutics, Inc.](https://specstream.ai/data/form-d/company/pierrepont-therapeutics-inc-2019360) $2.4 million · Sep 22, 2026

[Every Form D from the week of Dec 6, 2021](https://specstream.ai/data/form-d/week/2021-12-06) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Scopus BioPharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).